Journal
HEPATOLOGY
Volume 53, Issue 3, Pages 1023-1034Publisher
WILEY
DOI: 10.1002/hep.24148
Keywords
-
Categories
Funding
- Austrian Science Foundation [P18613-B05, F3008-B05]
- European Community [HEALTH-F2-2009-241762]
- Intercept
- Austrian Science Fund (FWF) [F 3008] Funding Source: researchfish
Ask authors/readers for more resources
Nuclear receptors are ligand-activated transcriptional regulators of several key aspects of hepatic physiology and pathophysiology. As such, nuclear receptors control a large variety of metabolic processes including hepatic lipid metabolism, drug disposition, bile acid homeostasis, as well as liver regeneration, inflammation, fibrosis, cell differentiation, and tumor formation. Derangements of nuclear receptor regulation and genetic variants may contribute to the pathogenesis and progression of liver diseases. This places nuclear receptors into the frontline for novel therapeutic approaches for a broad range of hepatic disorders and diseases including cholestatic and fatty liver disease, drug hepatotoxicity, viral hepatitis, liver fibrosis, and cancer. (HEPATOLOGY 2011;53:1023-1034)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available